Skip to main content
Top
Published in: Neurosurgical Review 1/2024

01-12-2024 | Deep Brain Stimulation | Correspondence

Letter: Ethical concerns and scientific communication on neuralink device

Authors: Daniele Armocida, Diego Garbossa, Fabio Cofano

Published in: Neurosurgical Review | Issue 1/2024

Login to get access

Excerpt

Dear editor, on January 29, 2024, Neuralink, a company founded by Elon Musk, made a momentous announcement that significantly impacted the field of neuroscience. This announcement was the successful implantation of the world’s first-ever “brain-reading device” into the human brain, representing a significant achievement in the realm of brain-computer interfaces (BCIs). The device, which was designed to record and decode brain activity, is intended to enable individuals with severe paralysis to control external devices, such as computers, robotic arms, and wheelchairs, simply by thinking about it. While the news was met with great interest and excitement, it also raised concerns among neurotechnology researchers. Some experts expressed cautious optimism about the device’s potential, whereas others noted that more research is needed to fully assess its safety and biocompatibility. …
Literature
Metadata
Title
Letter: Ethical concerns and scientific communication on neuralink device
Authors
Daniele Armocida
Diego Garbossa
Fabio Cofano
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Neurosurgical Review / Issue 1/2024
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-024-02432-x

Other articles of this Issue 1/2024

Neurosurgical Review 1/2024 Go to the issue